Guinea-Bissau vs Mauritania: Treatment coverage for schistosomiasis
Guinea-Bissau
8.5%
in 2024
Mauritania
12.6%
in 2024
Guinea-Bissau rank
42nd
Mauritania rank
40th
Treatment coverage for schistosomiasis over time
- Guinea-Bissau
- Mauritania
How they compare
Mauritania currently reports 12.6% against 8.5% in Guinea-Bissau, a difference of 4.1%.
That makes Mauritania's figure about 1.5 times Guinea-Bissau's.
The two have swapped places 3 times across 5 shared years of data; in 2015 it was Guinea-Bissau ahead.
Guinea-Bissau ranks 42nd and Mauritania ranks 40th of 45 countries.
Guinea-Bissau has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Guinea-Bissau | Mauritania | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 51.6% | 26.0% | 25.6% | Guinea-Bissau |
| 2020s | 29.6% | 13.9% | 15.7% | Guinea-Bissau |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment coverage for schistosomiasis, Guinea-Bissau or Mauritania?
- Mauritania, at 12.6% against 8.5% in Guinea-Bissau as of 2024.
- What is the difference in treatment coverage for schistosomiasis between Guinea-Bissau and Mauritania?
- 4.1%, with Mauritania ahead.
- How many years of comparable data are there for Guinea-Bissau and Mauritania?
- 5 years are reported by both, from 2015 to 2024.
- How do Guinea-Bissau and Mauritania rank globally for treatment coverage for schistosomiasis?
- Guinea-Bissau ranks 42nd and Mauritania ranks 40th of 45 countries.
- Where does this data come from?
- World Health Organization (2025) – with minor processing by Our World in Data, published as Treatment coverage for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Drug coverage out of estimated population who require it.